Columns

From the Field: Stop Throwing Away Your Money, Part 2

Rick Collins In the last issue of Nephrology Times I addressed two common ways in which healthcare providers spend money needlessly. The first was employing management personnel with no financial training and the second was contracting with incompetent vendors. While incompetent managers and vendors may be giving an honest effort, there are, unfortunately, managers and vendors that are intentionally dishonest ... Read More »

From the Chair: Treatment of Diabetic Nephropathy: Are we witnessing the dawn of a new era?

Ajay K. Singh, MBBS, FRPC, MBA Brigham and Women’s Hospital and Harvard Medical School Diabetic nephropathy is the most common cause of end-stage renal disease. With the rates of type 2 diabetes reaching epidemic proportions worldwide, it is likely that diabetes as a cause of kidney failure will continue to increase. The current treatment of diabetic nephropathy focuses on tight control ... Read More »

From the Field: Stop Throwing Away Your Money, Part I

By Rick Collins I am sickened by the many ways in which providers wind up spending money needlessly based on faulty or incomplete information. In this first of two articles, I identify two of the four most common areas which cause providers to waste money and make poor decisions. Employees in Authority Without Financial Skills In my experience, the most ... Read More »

From the Chair: What’s the Best Way to Treat Metastatic Renal Cell Cancer?

Renal cell carcinoma (RCC) accounts for 2% to 3% of all adult malignancies.1,2 It is the most common type of kidney cancer in adults, responsible for approximately 90% to 95% of cases. Approximately, one-third of patients with RCC present, at the time of diagnosis, with metastatic disease. In addition, approximately one-third of patients who present with localized disease also end ... Read More »

From The Board: Contrast This!

From the Board Kenneth Liss, DO Hypertension and Nephrology Associates Just when I think I am going to contribute to academe and scribe something about the latest nephrologic innovation or controversy, something in real life brings me to my senses and I have to vent. The latest 3 am phone call from an even more exhausted sounding surgical resident was ... Read More »

From the Field: Tips for Contract Negotiations

Rick Collins Tips for Contract Negotiations The emergence of Parsabiv™ (etelcalcetide) has spotlighted holes in provider contracts that resulted in lost reimbursement for renal providers. The loss of reimbursement could have been prevented in many cases had payer contracts been negotiated more wisely. In this month’s article we will look at contract terms that providers should avoid. While the examples ... Read More »

Guest Contributor: Breaking Down Barriers to Treatment Adherence for Dialysis Patients

LaVarne A. Burton President and CEO, American Kidney Fund Living with kidney failure is incredibly challenging for patients and their loved ones. Dialysis is a complex, demanding process that requires individuals stick closely to treatment for the best possible outcomes. Unfortunately, there are often unforeseen roadblocks standing in the way of adherence when adjusting to a rigorous new routine that ... Read More »

Self-Monitoring in Management of Hypertension  

Ajay K. Singh, MBBS, FRCP, MBA Brigham and Women’s Hospital and Harvard Medical School Boston, Massachusetts   One of the most common and problematic issues in the care of patients with chronic kidney disease (CKD) is the control of blood pressure. Hypertension is associated with both progression of CKD and with a higher rate of cardiovascular complications such as stroke ... Read More »

From the Field: KNOCKED SENSIPARLESS

Rick Collins Chief Operating Officer Sceptre Management Solutions, Inc.   KNOCKED SENSIPARLESS Patients and providers using Sensipar® (cinacalcet) and Parsabiv™ (etelcalcetide) are experiencing significantly increased financial liability due to inconsistent coverage of the drugs by payers and the dramatic increase in the coinsurance amount assigned by Medicare Part B. The biggest causes of potential lost reimbursement for providers are Medicare ... Read More »

From the Field: Losing Money by “Saving” Money

By Rick Collins and Sarah Tolson It is a saying I have never forgotten. “For a company to make a profit, you can cut costs or bring in more money. I prefer to bring in more money.” These words were spoken by the owner of a small company that was struggling to make ends meet. Over the years, I have ... Read More »